Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/28004| Title: | Combined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis. | Austin Authors: | Hilley, Patrick ;Gilmore, Robert B ;Srinivasan, Ashish ;Choy, Matthew C ;De Cruz, Peter P | Affiliation: | Medicine (University of Melbourne) Gastroenterology and Hepatology |
Issue Date: | 19-Aug-2021 | Publication information: | Inflammatory Bowel Diseases 2021; 27(9): e105-e106 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/28004 | DOI: | 10.1093/ibd/izab095 | ORCID: | 0000-0002-1627-2057 | Journal: | Inflammatory Bowel Diseases | PubMed URL: | 33999191 | Type: | Journal Article | Subjects: | Crohn disease combined biologics inflammatory bowel disease infliximab tofacitinib ulcerative colitis ustekinumab |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.